Themis Medicare Ltd vs Titan Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Themis Medicare Ltd is ₹ 104.25 as of 12 Jun 15:30 . The P/E Ratio of Themis Medicare Ltd changed from 7.2 on March 2021 to 45.3 on March 2025 . This represents a CAGR of 44.46% over 5 yearsThe P/E Ratio of Titan Biotech Ltd changed from 5.1 on March 2021 to 16.2 on March 2025 . This represents a CAGR of 26.01% over 5 years The Market Cap of Themis Medicare Ltd changed from ₹ 257.55 crore on March 2021 to ₹ 1349 crore on March 2025 . This represents a CAGR of 39.28% over 5 yearsThe Market Cap of Titan Biotech Ltd changed from ₹ 153.33 crore on March 2021 to ₹ 348.36 crore on March 2025 . This represents a CAGR of 17.84% over 5 years The revenue of Themis Medicare Ltd for the Mar '26 is ₹ 87.13 crore as compare to the Dec '25 revenue of ₹ 96.93 crore. This represent the decline of -10.11% The revenue of Titan Biotech Ltd for the Mar '26 is ₹ 50.94 crore as compare to the Dec '25 revenue of ₹ 57.76 crore. This represent the decline of -11.81% The ebitda of Themis Medicare Ltd for the Mar '26 is ₹ 14.36 crore as compare to the Dec '25 ebitda of ₹ 15.73 crore. This represent the decline of -8.71% The ebitda of Titan Biotech Ltd for the Mar '26 is ₹ 11.82 crore as compare to the Dec '25 ebitda of ₹ 12.09 crore. This represent the decline of -2.23% The net profit of Themis Medicare Ltd changed from ₹ 24.68 crore to ₹ 8.89 crore over 8 quarters. This represents a CAGR of -39.98% The net profit of Titan Biotech Ltd changed from ₹ 5.7 crore to ₹ 6.56 crore over 8 quarters. This represents a CAGR of 7.28% The Dividend Payout of Themis Medicare Ltd changed from 14.84 % on March 2021 to 19.23 % on March 2025 . This represents a CAGR of 5.32% over 5 yearsThe Dividend Payout of Titan Biotech Ltd changed from 4.31 % on March 2021 to 9.04 % on March 2025 . This represents a CAGR of 15.97% over 5 years .

About Themis Medicare Ltd

Themis Medicare Limited was formerly incorporated as 'Themis Chemicals Limited' in 1969.
The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April, 1993.
Thereafter, the name of the Company was changed to Themis Medicare Limited in 2001.
The Company is principally engaged in the business of manufacturing of finished formulations and synthetic Active Pharmaceutical Ingredients. In Mar.'95, the company came out with a public issue equity shares (premium : Rs 110) to finance the expansion-cum-modernisation of its synthetic bulk drug plant at Vapi, the setting up of a formulation unit at Lilora, Baroda as backward integration and to augment long-term working capital.

About Titan Biotech Ltd

Titan Biotech Limited, the New Delhi based company is into manufacture of Biological Peptones, Extracts and Dehydrated Culture media which are very conducive for the growth of micro organisms.
They are primarily used in the development and growth of micro organisms in clinical diagnosis production of vaccines antibiotics antisera etc, Checking the sensitivity of antibiotics in pharmaceutical industry, checking the bacterial contamination in food & water, tissue culture laboratories and in the departments of microbiology & botony in medical colleges/universities. The company uses Meat, Bile, Pancreatic, Liver, Blood, Brain, Heart and other parts of animals sourced from slaughter house and other vegetable products like soya, casein etc. converting them into free flowing powder to produce Peptones, Extracts and Hydrolysates which are further used in manufacturing of Dehydrated Culture Media and as raw material in pharma health products and other industries.

FAQs for the comparison of Themis Medicare Ltd and Titan Biotech Ltd

Which company has a larger market capitalization, Themis Medicare Ltd or Titan Biotech Ltd?

Market cap of Themis Medicare Ltd is 960 Cr while Market cap of Titan Biotech Ltd is 1,837 Cr

What are the key factors driving the stock performance of Themis Medicare Ltd and Titan Biotech Ltd?

The stock performance of Themis Medicare Ltd and Titan Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Themis Medicare Ltd and Titan Biotech Ltd?

As of June 14, 2026, the Themis Medicare Ltd stock price is INR ₹104.25. On the other hand, Titan Biotech Ltd stock price is INR ₹444.75.

How do dividend payouts of Themis Medicare Ltd and Titan Biotech Ltd compare?

To compare the dividend payouts of Themis Medicare Ltd and Titan Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.